Showing results (151-160 of 520) with videos related to
Sort By:
Pageof 52
Current Opinion in Oncology|September 19, 2014
An update on the risk prediction and prevention of anticancer therapy-induced cardiotoxicityManali Bhave, Ami N Shah, Nausheen Akhter, et al.Archives of Otolaryngology--Head & Neck Surgery|May 1, 1996
Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21)G L Clayman, T J Liu, S M Overholt, et al.Current Opinion in Oncology|December 4, 2015
Tumor microenvironment in mycosis fungoides and Sézary syndromeBelen Rubio Gonzalez, Jasmine Zain, Steven T Rosen, et al.International Journal of Dermatology|September 1, 1991
Naftifine treatment of trichomycosis pubisT Rosen, A M Krawczynska, M E McBride, et al.Journal of the American Academy of Dermatology|December 1, 1995
Dog, cat, and human bites: a reviewR D Griego, T Rosen, I F Orengo, et al.Cancer Research|September 1, 1993
Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cellsP A Moalli, S Pillay, N L Krett, et al.Placenta|March 16, 2015
STAT3 cooperates with the non-canonical NF-κB signaling to regulate pro-labor genes in the human placentaL J Yu, B Wang, N Parobchak, et al.Oncology (Williston Park, N.Y.)|September 4, 2014
Cancer metabolism as a therapeutic targetSurabhi Batra, Kehinde U A Adekola, Steven T Rosen, et al.Journal of Experimental Botany|June 3, 2026
Ethylene pretreatment drives cytosolic invertase-dependent changes in chloroplast biogenesis, photosynthesis, and metabolismEric Brenya, Mahipal S Rao, Ricardo Urquidi Camacho, et al.Hematological Oncology|January 1, 2026
International Cost-Effectiveness Analysis of Nivolumab Versus Brentuximab Vedotin for Patients With Advanced-Stage Classic Hodgkin's LymphomaYouwen Zhu, Kun Liu, Steven T Rosen, et al.Pageof 52